×

Back

IgA Nephropathy (IgAN) / IgA Vasculitis (IgAV)

KDIGO is updating The 2021 Clinical Practice Guideline for the Management of Glomerular Diseases on an ongoing, chapter-by-chapter basis.


The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) was recently available for public review. The guideline is now being prepared for publication, incorporating feedback received during the public review period. You can view the KDIGO IgAN/IgAV Guideline Public Review Draft Summary of Recommendations and Practice Points below. Please note: This is a draft document, and the content of this draft will change based on the feedback received during public review. The information contained in this document does not represent the final KDIGO IgAN/IgAV Guideline, is intended only as a reference document, and the distribution of the information contained therein is strictly prohibited.


This update considers evidence from randomized controlled trials published through April 2023. Brad Rovin, MD (United States), and Jürgen Floege, MD (Germany) co-chaired the guideline chapter updates and the 2021 KDIGO Glomerular Diseases Guideline.


View Guideline Public Review Draft

Guideline Suite

Guideline Resources


KDIGO IgA Nephropathy Infographics (2024)


Translations

DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES

This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.